Nemo-like Kinase Drives Foxp3 Stability and Is Critical for Maintenance of Immune Tolerance by Regulatory T Cells
Veerle Fleskens,
Carlos M. Minutti,
Xingmei Wu,
Ping Wei,
Cornelieke E.G.M. Pals,
James McCrae,
Saskia Hemmers,
Vincent Groenewold,
Harm-Jan Vos,
Alexander Rudensky,
Fan Pan,
Huabin Li,
Dietmar M. Zaiss,
Paul J. Coffer
Affiliations
Veerle Fleskens
Center for Molecular Medicine, Division of Pediatrics, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands
Carlos M. Minutti
Institute of Immunology and Infection Research, School of Biological Sciences, University of Edinburgh, Ashworth Laboratories, Edinburgh, UK
Xingmei Wu
ENT Department, Affiliated Eye and ENT Hospital, Fudan University, Shanghai, China
Ping Wei
Department of Otolaryngology, The Children’s Hospital of Chongqing Medical University, 136 Zhongshaner Road, Chongqing 400014, China
Cornelieke E.G.M. Pals
Center for Molecular Medicine, Division of Pediatrics, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands; Regenerative Medicine Center, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands
James McCrae
Institute of Immunology and Infection Research, School of Biological Sciences, University of Edinburgh, Ashworth Laboratories, Edinburgh, UK
Saskia Hemmers
Immunology Program, Howard Hughes Medical Institute, and Ludwig Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Vincent Groenewold
Hubrecht Institute, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands
Harm-Jan Vos
Proteins at Work, UMC Utrecht, Utrecht, the Netherlands
Alexander Rudensky
Immunology Program, Howard Hughes Medical Institute, and Ludwig Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Fan Pan
Immunology and Hematopoiesis Division, Department of Oncology, Bloomberg-Kimmel Institute, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Huabin Li
ENT Department, Affiliated Eye and ENT Hospital, Fudan University, Shanghai, China; Corresponding author
Dietmar M. Zaiss
Institute of Immunology and Infection Research, School of Biological Sciences, University of Edinburgh, Ashworth Laboratories, Edinburgh, UK; Corresponding author
Paul J. Coffer
Center for Molecular Medicine, Division of Pediatrics, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands; Regenerative Medicine Center, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands; Corresponding author
Summary: The Foxp3 transcription factor is a crucial determinant of both regulatory T (TREG) cell development and their functional maintenance. Appropriate modulation of tolerogenic immune responses therefore requires the tight regulation of Foxp3 transcriptional output, and this involves both transcriptional and post-translational regulation. Here, we show that during T cell activation, phosphorylation of Foxp3 in TREG cells can be regulated by a TGF-β activated kinase 1 (TAK1)-Nemo-like kinase (NLK) signaling pathway. NLK interacts and phosphorylates Foxp3 in TREG cells, resulting in the stabilization of protein levels by preventing association with the STUB1 E3-ubiquitin protein ligase. Conditional TREG cell NLK-knockout (NLKΔTREG) results in decreased TREG cell-mediated immunosuppression in vivo, and NLK-deficient TREG cell animals develop more severe experimental autoimmune encephalomyelitis. Our data suggest a molecular mechanism, in which stimulation of TCR-mediated signaling can induce a TAK1-NLK pathway to sustain Foxp3 transcriptional activity through the stabilization of protein levels, thereby maintaining TREG cell suppressive function. : The maintenance of Foxp3 expression is critical for correct TREG cell function. Fleskens et al. demonstrate a molecular mechanism in which TCR engagement can stabilize Foxp3 protein expression through TAK1-NLK-regulated phosphorylation, thereby maintaining TREG cell suppressive function. Keywords: Foxp3, phosphorylation, regulatory T cell, NLK, TCR, ubiquitination, immune tolerance